Campbell & Co Investment Adviser’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$694K Sell
60,850
-27,827
-31% -$276K 0.04% 675
2026
Q1
$817K Buy
88,677
+26,605
+43% +$221K 0.05% 575
2025
Q4
$461K Sell
62,072
-13,144
-17% -$90.1K 0.02% 859
2025
Q3
$511K Buy
75,216
+9,154
+14% +$62K 0.04% 720
2025
Q2
$456K Buy
66,062
+21,273
+47% +$144K 0.03% 819
2025
Q1
$326K Buy
+44,789
New +$352K 0.03% 829
2024
Q3
Sell
-55,672
Closed -$365K 1359
2024
Q2
$365K Buy
55,672
+3,087
+6% +$23.3K 0.03% 765
2024
Q1
$496K Buy
+52,585
New +$451K 0.04% 698
2023
Q4
Sell
-22,849
Closed -$154K 1366
2023
Q3
$154K Sell
22,849
-6,159
-21% -$50.5K 0.02% 875
2023
Q2
$284K Buy
29,008
+12,692
+78% +$129K 0.05% 690
2023
Q1
$158K Buy
+16,316
New +$142K 0.03% 756
2022
Q4
Sell
-39,966
Closed -$240K 1013
2022
Q3
$240K Sell
39,966
-31,264
-44% -$201K 0.05% 560
2022
Q2
$383K Buy
+71,230
New +$384K 0.1% 372

Other funds holding VMD

Campbell & Co Investment Adviser's VMD Position: Q2 2026 in Review

Campbell & Co Investment Adviser reduced its Viemed Healthcare (VMD) stake by 31% in Q2 2026, selling an estimated $276K and leaving 60,850 shares worth $694K. The position accounts for 0.04% of the portfolio, ranked #675.

Campbell & Co Investment Adviser first reported a position in VMD in Q2 2022 and has held it in 13 quarters since. The position peaked at $817K in Q1 2026. 42 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Campbell & Co Investment Adviser held 60,850 shares of Viemed Healthcare worth $694K as of Q2 2026.
  • Campbell & Co Investment Adviser sold 27,827 Viemed Healthcare shares in Q2 2026, an estimated $276K.
  • Viemed Healthcare made up 0.04% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #675 holding.
  • Campbell & Co Investment Adviser first reported a position in Viemed Healthcare in Q2 2022 and has held it in 13 quarters since.
  • Campbell & Co Investment Adviser's Viemed Healthcare position peaked at $817K in Q1 2026.
  • 42 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.